ArriVent BioPharma, Inc. (AVBP)
Data as of , from SEC Form 4 filings.
See up to 3 months of AVBP. The 7-day demo opens the 1M and 3M ranges and puts AVBP on your watchlist.
Start 7-day demoLatest AVBP insider trades
- HILLHOUSE INVESTMENT MANAGEMENT, LTD. - 10% OwnerOpen-market sale$12.98M
- Merdad Parsey - DirectorGrant or award13,562 sh
Kristine Peterson
About ArriVent BioPharma, Inc. (AVBP)
The SEC lists ArriVent BioPharma, Inc. under CIK 0001868279, in pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
AVBP Form 4 activity by transaction type, last 90 days
No Form 4 activity for AVBP in the last 90 days.
AVBP insider transactions (Form 4)
1611 Form 4 filings on record, the earliest from Jul 11, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Merdad Parsey - Director | Grant or award | Non-Qualified Stock Option (right to buy) | 13,562 | $0.00 | - | |
| Kristine Peterson - Director | Grant or award | Non-Qualified Stock Option (right to buy) | 13,562 | $0.00 | - | |
| John Hohneker - Director | Grant or award | Non-Qualified Stock Option (right to buy) | 13,562 | $0.00 | - | |
| Chris Nolet - Director | Grant or award | Non-Qualified Stock Option (right to buy) | 13,562 | $0.00 | - | |
| Robin Lachapelle - Officer | Grant or award | Stock Option (right to buy) | 130,000 | $0.00 | - | |
| Stuart Lutzker - Officer | Grant or award | Stock Option (right to buy) | 150,000 | $0.00 | - | |
| Winston Kung - Officer | Grant or award | Stock Option (right to buy) | 140,000 | $0.00 | - | |
| Zhengbin Yao - Officer | Grant or award | Stock Option (right to buy) | 550,000 | $0.00 | - | |
| James Paul Kastenmayer - Officer | Grant or award | Stock Option (right to buy) | 130,000 | $0.00 | - | |
| HILLHOUSE INVESTMENT MANAGEMENT, LTD. - 10% Owner | Open-market sale | Common Stock | 555,555 footnote F1 | $23.37 | $12.98M | |
| ||||||
| Robin Lachapelle - Officer | Option exercise | Common Stock | 2,050 | $2.28 | $5K | |
| Robin Lachapelle - Officer | Option exercise | Common Stock | 2,600 | $2.28 | $6K | |
| Robin Lachapelle - Officer | Option exercise | Common Stock | 6,503 | $2.28 | $15K | |
| Robin Lachapelle - Officer | Option exercise | Stock Option (right to buy) | 2,050 | $0.00 | - | |
| Robin Lachapelle - Officer | Option exercise | Stock Option (right to buy) | 2,600 | $0.00 | - | |
| Robin Lachapelle - Officer | Option exercise | Stock Option (right to buy) | 6,503 | $0.00 | - | |
AVBP insider trading FAQ
What is the latest insider trade for AVBP?
ArriVent BioPharma, Inc. (AVBP) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-23. The full record for AVBP runs to 11 Form 4 filings, the earliest from 2025-07-11. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying AVBP stock?
No insider purchases of AVBP were filed in the last 90 days.
How many insiders are selling AVBP stock?
No insider sales of AVBP were filed in the last 90 days. 1 sale is on record for this company.
Where can I see AVBP SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects AVBP Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Merdad Parsey view on EDGAR
- - Kristine Peterson view on EDGAR
- - John Hohneker view on EDGAR
- - Chris Nolet view on EDGAR
- - Robin Lachapelle view on EDGAR
- - Stuart Lutzker view on EDGAR
- - Winston Kung view on EDGAR
- - Zhengbin Yao view on EDGAR
- - James Paul Kastenmayer view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where AVBP's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow AVBP with a 7-day demo
- AVBP on your watchlist
- Every AVBP Form 4 filing on record
- Up to 3 months of AVBP price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
